Author:
Turski Gabrielle N.,Ikonomidou Chrysanthy
Reference275 articles.
1. Aarts, M., Liu, Y., Liu, L., Besshoh, S., Arundine, M., Gurd, J. W., Wang, Y. T., Salter, M. W., & Tymianski, M. (2002). Treatment of ischemic brain damage by perturbing NMDA receptor- PSD-95 protein interactions. Science, 298, 846–850.
2. Abe, T., Sugihara, H., Nawa, H., Shigemoto, R., Mizuno, N., & Nakanishi, S. (1992). Molecular characterization of a novel metabotropic glutamate receptor mGluR5 coupled to inositol phosphate/Ca2+ signal transduction. The Journal of Biological Chemistry, 267, 13361–13368.
3. Adler, C. H., Stern, M. B., Vernon, G., & Hurtig, H. I. (1997). Amantadine in advanced Parkinson’s disease: Good use of an old drug. Journal of Neurology, 244, 336–337.
4. Albers, G. W., Goldstein, L. B., Hall, D., Lesko, L. M., & Aptiganel Acute Stroke Investigators. (2001). Aptiganel hydrochloride in acute ischemic stroke: A randomized controlled trial. Journal of the American Medical Association, 286, 2673–2682.
5. Andersen, P. M. (2001). Genetics of sporadic ALS. Amyotrophic Lateral Sclerosis and Other Motor Neuron Disorders, 2, S37–S41.
Cited by
3 articles.
订阅此论文施引文献
订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献